Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

about

Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

Item

http://www.wikidata.org/entity/Q43109001

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@en

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@nl

type

Item

label

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@en

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@nl

prefLabel

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@en

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@nl

P1476

Presensitization to HY antigen ...... nt nor with clinical outcomes.

@en

P2093

Bita Sahaf

http://www.w3.org/2001/XMLSchema#string

Center for International Blood and Marrow Transplantation

http://www.w3.org/2001/XMLSchema#string

Christine E Ryan

http://www.w3.org/2001/XMLSchema#string

David B Miklos

http://www.w3.org/2001/XMLSchema#string

Fang Wu

http://www.w3.org/2001/XMLSchema#string

Hideki Nakasone

http://www.w3.org/2001/XMLSchema#string

Jerome Ritz

http://www.w3.org/2001/XMLSchema#string

Kelsi Schoenrock

http://www.w3.org/2001/XMLSchema#string

Lu Tian

http://www.w3.org/2001/XMLSchema#string

Michael D Haagenson

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Current issues in chronic graft-versus-host disease.

H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.

Clinical impact of H-Y alloimmunity

Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.

H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Recombinant antigen microarrays for serum/plasma antibody detection.

Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Sperm exposure during menses is a risk factor for developing antisperm antibody (ASA) in female.

P304

e30-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2015.134551

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26494841

http://www.w3.org/2001/XMLSchema#string

P932

4697905

http://www.w3.org/2001/XMLSchema#string